Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

CV Sciences (CVSI) Raw Materials (2016 - 2025)

Historic Raw Materials for CV Sciences (CVSI) over the last 12 years, with Q3 2025 value amounting to $2.4 million.

  • CV Sciences' Raw Materials fell 906.04% to $2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.4 million, marking a year-over-year decrease of 906.04%. This contributed to the annual value of $2.6 million for FY2024, which is 1075.38% down from last year.
  • Latest data reveals that CV Sciences reported Raw Materials of $2.4 million as of Q3 2025, which was down 906.04% from $2.5 million recorded in Q2 2025.
  • CV Sciences' Raw Materials' 5-year high stood at $4.6 million during Q3 2021, with a 5-year trough of $2.4 million in Q1 2025.
  • Over the past 5 years, CV Sciences' median Raw Materials value was $3.2 million (recorded in 2023), while the average stood at $3.3 million.
  • Per our database at Business Quant, CV Sciences' Raw Materials crashed by 509.31% in 2021 and then crashed by 2102.98% in 2022.
  • CV Sciences' Raw Materials (Quarter) stood at $4.0 million in 2021, then decreased by 11.43% to $3.6 million in 2022, then fell by 18.83% to $2.9 million in 2023, then dropped by 10.75% to $2.6 million in 2024, then dropped by 5.5% to $2.4 million in 2025.
  • Its last three reported values are $2.4 million in Q3 2025, $2.5 million for Q2 2025, and $2.4 million during Q1 2025.